THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK ...
Nothing" Marijuana Mess: Why MMJ International Holdings Takes the Lead in a Pharmaceutical Cannabis Reset.Dispensaries sell products. MMJ builds medicine. And as the country re-learns the difference, ...
Nippon Electric Glass Co., Ltd. (NEG)(TOKYO:5214), a global leader in specialty glass headquartered in Otsu, Japan, announced it will begin the world’s first mass production of pharmaceutical-grade ...
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced that ...
ATHÈNES, Grèce--(BUSINESS WIRE)-- COMMUNIQUÉ DESTINÉ UNIQUEMENT AUX MÉDIAS EUROPÉENS SPÉCIALISÉS DANS LES DOMAINES MÉDICAL, PHARMACEUTIQUE ET FINANCIER Genesis Pharma, société biopharmaceutique région ...
Collaboration to focus on building a leading, US-based biotech dedicated to addressing underserved patients impacted by autoimmune and endocrinology disordersGenSci to receive $70 million ...
Hercules Pharmaceuticals today announced the appointment of Ali Ahmed as Executive Vice President, Chief Commercial Officer.
First and only transgenic chicken platform engineered to express ultralong CDRH3 domains on a human antibody framework ...
John Johnson, current board member, appointed to chairman of the boardMichael Kauffman, M.D., Ph.D., lead director since 2016, appointed to president of developmentCommercial launch progresses as RAMP ...
Immunome, Inc. (“Immunome”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced its plans to commence an ...
WASHINGTON, D.C. / ACCESS Newswire / December 15, 2025 / Leading national organizations have come together to form the Alliance to Strengthen America's Health Workforce for the Underserved, a ...
The program is designed with a novel, liver-detargeting, muscle-tropic capsid intended to improve safety and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback